Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A
about
Novel formulations for antimicrobial peptidesImmunosuppressive and anti-inflammatory properties of engineered nanomaterialsFormulation Strategy for the Delivery of Cyclosporine A: Comparison of Two Polymeric Nanospheres.Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action.Size-dependent tumor penetration and in vivo efficacy of monodisperse drug-silica nanoconjugates.Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance.Novel pentablock copolymer-based nanoparticulate systems for sustained protein delivery.Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: An in vitro-in vivo study.Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication.Harnessing Apoptotic Cells for Transplantation Tolerance: Current Status and Future Perspectives.Nanotechnological Approaches to Immunosuppression and Tolerance Induction.Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
P2860
Q26991771-5DFC4FDA-5360-4584-8D8B-3299018F531BQ27005267-0CD79501-41ED-42A7-B2D5-6DB0046AF20EQ35948778-8FF61C1E-660F-4721-BE44-4A7E76B76E6CQ36356343-701AE68B-9D3A-4ECA-B10C-30D65DE42C8CQ36971700-B1EFFC1F-BEC0-4718-80E4-6C1509FAAEC3Q38297557-CA7B83D9-C54E-4111-9B0C-D2AF09A24E57Q38947571-7C6563BB-C044-4F5C-B64E-4AB1DCFF6169Q41317682-668E19BE-DF62-4D09-AAC6-10CA32284582Q41488466-8A45D650-CFF1-42CE-A0C8-C01678748862Q47816665-C89F2512-2845-48DD-96AE-61483C571B17Q50066247-E75BAED6-21EC-4D60-A4BA-00FFA9208FE3Q53231233-AF59BE18-CC21-495B-B5E8-7E793569DB05
P2860
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immunosuppressive Activity of ...... ng Encapsulated Cyclosporine A
@ast
Immunosuppressive Activity of ...... ng Encapsulated Cyclosporine A
@en
type
label
Immunosuppressive Activity of ...... ng Encapsulated Cyclosporine A
@ast
Immunosuppressive Activity of ...... ng Encapsulated Cyclosporine A
@en
prefLabel
Immunosuppressive Activity of ...... ng Encapsulated Cyclosporine A
@ast
Immunosuppressive Activity of ...... ng Encapsulated Cyclosporine A
@en
P2093
P2860
P356
P1476
Immunosuppressive Activity of ...... ng Encapsulated Cyclosporine A
@en
P2093
Jamil Azzi
Jianjun Cheng
Marwan Mounayar
Mincheol Kwon
Nikolaos Skartsis
Robert Moore
P2860
P304
P356
10.1155/2012/896141
P577
2012-03-29T00:00:00Z